These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12445426)

  • 1. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients.
    Westin J; Nordlinder H; Lagging M; Norkrans G; Wejstål R
    J Hepatol; 2002 Dec; 37(6):837-42. PubMed ID: 12445426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the prevalence and grade of steatosis in patients with chronic hepatitis C with the host and viral factors.
    Liakina V; Speiciené D; Irnius A; Semuchiniené T; Valantinas J
    Acta Gastroenterol Belg; 2007; 70(3):260-6. PubMed ID: 18074734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of steatosis and inflammation on liver fibrosis in chronic hepatitis C.
    Nieminen U; Arkkila PE; Kärkkäinen P; Färkkilä MA
    Liver Int; 2009 Feb; 29(2):153-8. PubMed ID: 18482270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TM6SF2 E167K variant predicts severe liver fibrosis for human immunodeficiency/hepatitis C virus co-infected patients, and severe steatosis only for a non-3 hepatitis C virus genotype.
    Sagnelli C; Merli M; Uberti-Foppa C; Hasson H; Grandone A; Cirillo G; Salpietro S; Minichini C; Starace M; Messina E; Morelli P; Miraglia Del Giudice E; Lazzarin A; Coppola N; Sagnelli E
    World J Gastroenterol; 2016 Oct; 22(38):8509-8518. PubMed ID: 27784963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic steatosis at 1 year is an additional predictor of subsequent fibrosis severity in liver transplant recipients with recurrent hepatitis C virus.
    Brandman D; Pingitore A; Lai JC; Roberts JP; Ferrell L; Bass NM; Terrault NA
    Liver Transpl; 2011 Dec; 17(12):1380-6. PubMed ID: 21770018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity.
    Adinolfi LE; Gambardella M; Andreana A; Tripodi MF; Utili R; Ruggiero G
    Hepatology; 2001 Jun; 33(6):1358-64. PubMed ID: 11391523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?
    Sharma P; Balan V; Hernandez J; Rosati M; Williams J; Rodriguez-Luna H; Schwartz J; Harrison E; Anderson M; Byrne T; Vargas HE; Douglas DD; Rakela J
    Dig Dis Sci; 2004 Jan; 49(1):25-9. PubMed ID: 14992430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
    Patton HM; Patel K; Behling C; Bylund D; Blatt LM; Vallée M; Heaton S; Conrad A; Pockros PJ; McHutchison JG
    J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worsening of steatosis is an independent factor of fibrosis progression in untreated patients with chronic hepatitis C and paired liver biopsies.
    Castéra L; Hézode C; Roudot-Thoraval F; Bastie A; Zafrani ES; Pawlotsky JM; Dhumeaux D
    Gut; 2003 Feb; 52(2):288-92. PubMed ID: 12524415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M; La Mura V; Bruno S; Gaeta GB; Vecchione R; Carrino F; Moschella F; Torella R; Persico M
    J Viral Hepat; 2007 Oct; 14(10):714-20. PubMed ID: 17875006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.
    Castéra L; Hézode C; Roudot-Thoraval F; Lonjon I; Zafrani ES; Pawlotsky JM; Dhumeaux D
    Gut; 2004 Mar; 53(3):420-4. PubMed ID: 14960527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus infection and liver steatosis.
    Ramalho F
    Antiviral Res; 2003 Oct; 60(2):125-7. PubMed ID: 14638408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic steatosis is associated with fibrosis, nucleoside analogue use, and hepatitis C virus genotype 3 infection in HIV-seropositive patients.
    McGovern BH; Ditelberg JS; Taylor LE; Gandhi RT; Christopoulos KA; Chapman S; Schwartzapfel B; Rindler E; Fiorino AM; Zaman MT; Sax PE; Graeme-Cook F; Hibberd PL
    Clin Infect Dis; 2006 Aug; 43(3):365-72. PubMed ID: 16804853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.
    Prieto M; Berenguer M; Rayón JM; Córdoba J; Argüello L; Carrasco D; García-Herola A; Olaso V; De Juan M; Gobernado M; Mir J; Berenguer J
    Hepatology; 1999 Jan; 29(1):250-6. PubMed ID: 9862874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for steatosis progression in adults coinfected with HIV and hepatitis C virus.
    Woreta TA; Sutcliffe CG; Mehta SH; Brown TT; Higgins Y; Thomas DL; Torbenson MS; Moore RD; Sulkowski MS
    Gastroenterology; 2011 Mar; 140(3):809-17. PubMed ID: 21134375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.
    Hu KQ; Currie SL; Shen H; Cheung RC; Ho SB; Bini EJ; McCracken JD; Morgan T; Bräu N; Schmidt WN; Jeffers L; Wright TL;
    Dig Dis Sci; 2007 Feb; 52(2):570-8. PubMed ID: 17226072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological findings and clinical characteristics associated with hepatic steatosis in patients coinfected with HIV and hepatitis C virus.
    Marks KM; Petrovic LM; Talal AH; Murray MP; Gulick RM; Glesby MJ
    J Infect Dis; 2005 Dec; 192(11):1943-9. PubMed ID: 16267765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.
    Rodríguez-Torres M; Govindarajan S; Solá R; Clumeck N; Lissen E; Pessôa M; Buggisch P; Main J; Depamphilis J; Dieterich DT
    J Hepatol; 2008 May; 48(5):756-64. PubMed ID: 18314217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Steatosis and non-alcoholic steatohepatitis in patients with chronic hepatitis due to hepatitis C virus infection].
    Coral G; de Mattos AA; de Mattos AZ; dos Santos DE
    Arq Gastroenterol; 2006; 43(4):265-8. PubMed ID: 17406752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.